Shohei Tsuji
Overview
Explore the profile of Shohei Tsuji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Uchida Y, Nakao M, Yamada S, Tsuji S, Uemura H, Kouyama J, et al.
PLoS One
. 2022 Feb;
17(2):e0262764.
PMID: 35180213
Background: To evaluate the long-term efficacy of switching of the nucleos(t)ide analog used for treatment from entecavir (ETV) to tenofovir alafenamide fumarate (TAF) in patients with chronic HBV infection. Methods:...
12.
Alamin M, Tsuji S, Hata A, Hara-Yamamura H, Honda R
Sci Total Environ
. 2022 Feb;
823:153737.
PMID: 35149069
Since SARS-CoV-2 RNA in wastewater is often present at low concentration or under detection limit, ensuring the reliability of detection processes using appropriate process controls is essential. The objective of...
13.
Uchida Y, Uemura H, Tsuji S, Yamada S, Kouyama J, Naiki K, et al.
Hepatol Res
. 2022 Feb;
52(5):449-461.
PMID: 35113468
Background: The Japanese guidelines for the treatment of cirrhosis suggest zinc supplementation to prevent hepatic encephalopathy in patients with cirrhosis and zinc deficiency, although the factors that are associated with...
14.
Matsubara H, Imai T, Tsuji S, Oka N, Egashira Y, Enomoto Y, et al.
J Pharmacol Sci
. 2022 Jan;
148(2):279.
PMID: 35063144
No abstract available.
15.
Matsubara H, Imai T, Tsuji S, Oka N, Egashira Y, Enomoto Y, et al.
J Pharmacol Sci
. 2021 Dec;
148(1):65-72.
PMID: 34924132
This study aimed to evaluate the effects of nafamostat, a serin protease inhibitor, in the management of subarachnoid hemorrhage (SAH). SAH was induced by endovascular perforation in male mice. Nafamostat...
16.
Matsubara H, Imai T, Tsuji S, Oka N, Ohba T, Yamada T, et al.
J Stroke Cerebrovasc Dis
. 2021 Jul;
30(9):105952.
PMID: 34214963
Objective: Cerebral Blood Flow (CBF) change after Subarachnoid Hemorrhage (SAH) is strongly associated with brain injuries such as early brain injury and delayed cerebral ischemia. We evaluated the correlation between...
17.
Tsuji S, Nakamura S, Yamada T, de Vega S, Okada Y, Inoue S, et al.
Brain Res
. 2021 Apr;
1764:147490.
PMID: 33887254
Glioblastoma is the most malignant tumor of the brain associated with poor prognosis and outcome, and hence there is an urgent need to develop novel treatments for glioblastoma. In this...
18.
Kambara A, Kajimoto Y, Yagi R, Ikeda N, Furuse M, Nonoguchi N, et al.
Front Aging Neurosci
. 2021 Feb;
12:617150.
PMID: 33551791
The long-term prognosis of cognitive function in patients with idiopathic normal pressure hydrocephalus (iNPH) remains unclear. This study aimed to determine the long-term prognosis of cognitive function in patients with...
19.
Nakamura S, Maoka T, Tsuji S, Hayashi M, Shimazawa M, Hara H
J Nutr Sci Vitaminol (Tokyo)
. 2020 Nov;
66(5):488-494.
PMID: 33132354
Astaxanthin, which has been shown to have significant antioxidant activity, is rapidly spreading as a health functioning ingredient in the health food and cosmetics sectors worldwide. It is well known...
20.
Tsuji S, Nakamura S, Maoka T, Yamada T, Imai T, Ohba T, et al.
Mar Drugs
. 2020 Sep;
18(9).
PMID: 32962073
Several antitumour drugs have been isolated from natural products and many clinical trials are underway to evaluate their potential. There have been numerous reports about the antitumour effects of astaxanthin...